Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in Acute Ischemic Stroke (TNK-S2B)
NCT00252239Phase 2Terminated
- Sponsor
- University of Virginia
- Start
- Nov 2005
- Primary completion
- Mar 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tenecteplase in ischemic stroke (4 arms), sponsored by University of Virginia. Primary endpoint: Modified Rankin Score at 3 months. Started Nov 2005; status: terminated.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00252239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252239.